Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06333288 · ClinicalTrials.gov registry record · NA
Pilot Trial to Evaluate PROblem Solving Therapy and APPLE Watch for College Students
A NA study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT06333288: Completed NA study, sponsored by University of Illinois at Chicago.
NCT06333288 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06333288, a NA study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The goals of this Pilot Trial are to test the preliminary efficacy of Problom-Solving Therapy (PST)-APPLE Watch in a 2-arm pilot Randomized Control Trial (RCT), vs education only-control to reduce alcohol use disorder symptoms and improve alcohol abstinence.
Primary Outcome
Participants will be monitored for 3 months to assess alcohol abstinence by blood alcohol content.
Interventions
- BEHAVIORAL PST-APPLE Watch group
- BEHAVIORAL Education-only control group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2024-04-15 |
| Est. Completion | 2024-11-30 |
| Phase | NA |
What the finished NCT06333288 record still lists
NCT06333288 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which PST-APPLE Watch group is the first listed.
NCT06333288 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06333288 about?
NCT06333288 is a clinical study titled "Pilot Trial to Evaluate PROblem Solving Therapy and APPLE Watch for College Students". The goals of this Pilot Trial are to test the preliminary efficacy of Problom-Solving Therapy (PST)-APPLE Watch in a 2-arm pilot Randomized Control Trial (RCT), vs education only-control to reduce alcohol use disorder symptoms and improve alcohol abstinence.
What is the current status of trial NCT06333288?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2024-04-15. Estimated completion is 2024-11-30.
What interventions are being tested in trial NCT06333288?
The interventions under investigation include: PST-APPLE Watch group (BEHAVIORAL), Education-only control group (BEHAVIORAL).
Who is sponsoring clinical trial NCT06333288?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06333288's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI